Method of treating cardiovascular disease
AssigneeWyeth
InventorsNeal I. Azrolan, Surendra N. Sehgal, Steven J. Adelman
Life of this patent
Estimating the term…
Abstract
This invention provides a method of treating or inhibiting cardiovascular, cerebral vascular, or peripheral vascular disease in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
Claims39
A method of treating or inhibiting cardiovascular, cerebral vascular, or peripheral vascular disease in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
A method of treating or inhibiting coronary artery disease, cerebrovascular disease, arteriosclerosis, atherosclerosis, nonatheromatous arteriosclerosis, or vascular wall damage from cellular events leading toward immune mediated vascular damage in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
A method of inhibiting stroke, multiinfarct dementia, or transient ischemic attack in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
A method of treating or inhibiting lipid deposition or accumulation in a vascular wall in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
A method of treating or inhibiting acute coronary syndrome in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
A method of treating or inhibiting ischemic reperfusion injury in a mammal in need thereof, which comprises providing said mammal with an effective amount of a rapamycin.
Dependencies are inferred from the claim text.